fda category 2 bulk drug substances bpc 157 list news bpc-157 compounding HHS Secretary RFK Jr. just dropped major news: the FDA is removing 12 peptides from its restrictive Category 2 list — reversing the 2023 Client Alert: Navigating the Peptide

Further support for BPC 157/serotonin relation is the inhibited release of enteric serotonin and inhibited intestinal motility, the increased survival rate of cultured enteric neurons, and the increased proliferation of cultured enteric glial cells (EGCs) by BPC 157 application [119]

SynaPep BPC-157 is an advanced oral peptide therapy designed to support tissue repair, calm persistent inflammation, and promote more efficient recovery

Frequency of Administration: For significant deficiencies, initial injections may be given weekly, while others may only need monthly shots

01 The Treatment NAD is administered as a simple intramuscular injection, typically in the arm or hip

Non-Invasive: Unlike injections, oral supplements do not require needles or syringes, making them a preferred option for individuals with needle phobias